Skip to main content
Clinical Trials/NCT04633291
NCT04633291
Completed
Not Applicable

Clinical Study in Healthy Volunteers Evaluating the Performance and Handling of a Urinary Intermittent Catheter With a Newly Developed Swelling Media.

Coloplast A/S1 site in 1 country22 target enrollmentNovember 5, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Catheter Site Pain
Sponsor
Coloplast A/S
Enrollment
22
Locations
1
Primary Endpoint
Overall Discomfort During Nurse Catheterization
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Investigation of novel swelling media for CE marked intermittent urinary catheters. The study was a randomized, single blinded, cross-over investigation comparing a novel swelling media with a comparator swelling media in 22 adult, healthy, male volunteers.

Detailed Description

The CP279 study investigated a novel swelling media for male intermittent urinary catheters. The study was conducted in Denmark and was a single-site, randomized, single blinded, cross-over investigation, testing inferiority of a novel catheter swelling media against a comparator swelling media in 22 adult, healthy, male volunteers. Each participant was randomized to one of two treatment arms, using a randomization sequence of two (i.e., with two different random options for the order in which the participants tested the two swelling media). The study thus contained two test visits, for which the 22 participants tested the two different swelling media, respectively. There was 4-14 days between the test visits and all catheterizations were performed by trained nurses. Due to a visual difference between the products, it was only possible to blind the subjects.

Registry
clinicaltrials.gov
Start Date
November 5, 2019
End Date
November 28, 2019
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Written informed consent given
  • Minimum 18 years of age and with full legal capacity
  • Male gender
  • Willing to refrain from using analgesics up to 24 hours prior to catheterization visits
  • Negative urine multistix analysis for erythrocytes (microscopic hematuria)
  • Negative urine multistix analysis for leukocytes and nitrite, or if positive, subsequent negative for bacterial growth in urine culture

Exclusion Criteria

  • Abnormalities, diseases or surgical procedures performed in the lower urinary tract
  • Symptoms of urinary tract infections (at least one of the following: frequent urination, stinging or pain at urination)
  • Participating in other clinical investigations related to urinary tracts system during this investigation (inclusion to termination) or previously participation in this investigation
  • Known hypersensitivity toward any of the investigational device

Outcomes

Primary Outcomes

Overall Discomfort During Nurse Catheterization

Time Frame: Immediately after the procedure/catheterization, up to 5 min.

Discomfort measured for the entire catheterization procedure (performed by nurse), using the Visual Analogue Scale (VAS). The VAS is a tool used to rate the intensity of certain sensations and feelings, e.g. discomfort/pain. It is a straight line of 10 cm (in this case horizontal) with one end meaning no discomfort/pain (0 cm) and the other end meaning the worst discomfort/pain imaginable (10 cm). The subject visualizes and marks a point on the line that matches the amount of discomfort/pain experienced. A high score reflects a worse outcome than a lower score.

Secondary Outcomes

  • Urination Discomfort After Catheterization(Immediately after first normal void, up to 5 min.)
  • Catheter Handling During Insertion(Immediately after the procedure/catheterization, up to 5 min.)
  • Touch of Catheter Coating(Immediately after the procedure/catheterization, up to 5 min.)
  • Insertion Discomfort During Nurse Catheterization(Immediately after the procedure/catheterization, up to 5 min.)
  • Withdrawal Discomfort During Nurse Catheterization(Immediately after the procedure/catheterization, up to 5 min.)
  • Catheter Handling During Withdrawal(Immediately after the procedure/catheterization, up to 5 min.)
  • Visual Blood During Catheterization(Immediately after the procedure/catheterization, up to 5 min.)
  • Microscopic Blood in Catheter-collected Urine(Immediately after the procedure/catheterization, up to 30 min.)

Study Sites (1)

Loading locations...

Similar Trials